Evidence map›Paper›PMID 36400879›Full record

ArticleScientific reports2022

Delivery of the reduced form of vitamin K

Erina Toki, Shotaro Goto, Shuichi Setoguchi, Kazuki Terada, Daisuke Watase, Hirofumi Yamakawa, Ayano Yamada, Mitsuhisa Koga, Kaori Kubota, Katsunori Iwasaki and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Erina TokiFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, 814-0180, Japan.
Shotaro GotoFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, 814-0180, Japan.
Shuichi SetoguchiFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, 814-0180, Japan.
Kazuki TeradaFaculty of Pharmaceutical Sciences, Himeji Dokkyo University, Himeji, 670-8524, Japan.
Daisuke WataseFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, 814-0180, Japan.
Hirofumi YamakawaRadioisotope Center, Fukuoka University, Fukuoka, 814-0180, Japan.
Ayano YamadaFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, 814-0180, Japan.
Mitsuhisa KogaFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, 814-0180, Japan.
Kaori KubotaFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, 814-0180, Japan.
Katsunori IwasakiFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, 814-0180, Japan.
Yoshiharu KarubeFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, 814-0180, Japan.
Kazuhisa MatsunagaFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, 814-0180, Japan. k-matsu@fukuoka-u.ac.jp.
Jiro TakataFaculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, 814-0180, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria generate energy through the action of the electron transport chain (ETC) and ATP synthase. Mitochondrial malfunction can lead to various disorders, including neurodegenerative diseases. Several reports have shown that menaquinone-4 (MK-4, vitamin K

Indexed as

ProdrugsRotenone3T3 CellsAnimalsCell DeathMiceReactive Oxygen SpeciesProdrugsReactive Oxygen SpeciesRotenone

Identifiers

PMID36400879
PMCPMC9674836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.